Effective chronic care management for human and animal health.
We develop solutions for sustainably providing measurable health information, enabling frequent patient/provider interactions. Our technology enhances adherence-to-care-plans, improving outcomes and containing healthcare costs.
Connecting clinicians and patients.
Our diabetes management solutions shift the current patient self-care model to a more effective and efficient active patient management model by connecting the clinicians, patients, testing supplies, and health data together through our groundbreaking technology
Multi-market glucose monitoring solution.
We adapted our diabetes management solution to serve the desperate need in animal health for better glucose testing & monitoring by offering the GluCurve Pet CGM which combines both the industry first CGM for pets with the first of its kind patient management portal.
ALR Technologies Releases an Open Letter to Shareholders
The diabetes management company, today releases an open letter to shareholders from Chairman and Chief Executive Officer Sidney Chan
ALR Technologies and Infinovo Sign Memorandum of Understanding to Manufacture World’s First CGM for Diabetic Pets
The diabetes management company, is pleased to announce the signing of a Memorandum of Understanding (“MOU”) with Infinovo Medical Co. Ltd
Why invest in ALRT?
We believe diabetes is among the top drivers of healthcare costs, morbidity, and mortality because of two reasons, Clinical Inertia- failure to advance therapy on a timely basis, and patient self-management. We have worked to solve these two issues through first of their kind features such as active patient management, patent pending predictive A1C, FDA cleared insulin dose adjustments, non-insulin therapy advancements, direct meter uploads, data processing, remote care, and more!